Fund Holdings — STEMPOINT CAPITAL LP

Total Portfolio Value:
$339.93M
Total Bought:
$120.48M
Total Sold:
$125.50M
Net Transaction:
-$5.02M
Notable People:
Michelle Avra Ross
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Syndax Pharmaceuticals, Inc.(SNDX)1,100,9881,412,176+311,188$26.20M$28.99M8.53%+$2.79M
Roivant Sciences Ltd.SHS(ROIV)3,553,8442,712,741-841,103$37.46M$28.67M8.44%-$8.78M
Immunovant, Inc.(IMVT)627,2281,011,879+384,651$20.27M$26.71M7.86%+$6.45M
Crinetics Pharmaceuticals In619,789551,095-68,694$29.01M$24.68M7.26%-$4.33M
Merus N V233,871288,668+54,797$10.53M$17.08M5.02%+$6.55M
Arcellx Inc
COMMON STOCK
140,267280,709+140,442$9.76M$15.49M4.56%+$5.74M
Amicus Therapeutics Inc
COM
1,547,1411,495,047-52,094$18.23M$14.83M4.36%-$3.39M
Immunocore Holdings plcADS(IMCR)0339,351+339,351$0$11.50M3.38%+$11.50M
Applied Therapeutics Inc2,017,0162,211,320+194,304$13.72M$10.33M3.04%-$3.39M
Merck & Co., Inc.(MRK)081,508+81,508$0$10.15M2.99%+$10.15M
GSK plcADR(GSK)0245,933+245,933$0$9.47M2.79%+$9.47M
Autolus Therapeutics plcADS(AUTL)2,965,7212,662,732-302,989$18.92M$9.27M2.73%-$9.65M
Arcutis Biotherapeutics, Inc.(ARQT)2,205,899965,392-1,240,507$21.86M$8.98M2.64%-$12.88M
Cabaletta Bio, Inc.(CABA)1,003,9161,178,105+174,189$17.13M$8.81M2.59%-$8.31M
Kalvista Pharmaceuticals Inc1,161,060736,765-424,295$13.77M$8.68M2.55%-$5.09M
Biohaven Ltd.(BHVN)83,461233,255+149,794$4.56M$8.10M2.38%+$3.53M
Vistagen Therapeutics, Inc.(VTGN)1,848,5821,848,5820$9.29M$5.85M1.72%-$3.44M
Immatics N.V.SHS(IMTX)491,926502,207+10,281$5.17M$5.84M1.72%+$665.5K
Denali Therapeutics Inc.(DNLI)0251,010+251,010$0$5.83M1.71%+$5.83M
Insmed Incorporated(INSM)272,44886,980-185,468$7.39M$5.83M1.71%-$1.56M
Celldex Therapeutics, Inc.(CLDX)0144,467+144,467$0$5.35M1.57%+$5.35M
Larimar Therapeutics, Inc.(LRMR)740,877704,349-36,528$5.62M$5.11M1.50%-$516.7K
TScan Therapeutics, Inc.(TCRX)0845,069+845,069$0$4.94M1.45%+$4.94M
Edgewise Therapeutics, Inc.(EWTX)0271,057+271,057$0$4.88M1.44%+$4.88M
Corbus Pharmaceuticals Holdings, Inc.(CRBP)0101,479+101,479$0$4.59M1.35%+$4.59M
Fulcrum Therapeutics, Inc.(FULC)407,108696,464+289,356$3.84M$4.32M1.27%+$475.0K
Nurix Therapeutics, Inc.(NRIX)0203,273+203,273$0$4.24M1.25%+$4.24M
Pyxis Oncology, Inc.(PYXS)1,794,1951,202,675-591,520$7.64M$3.98M1.17%-$3.66M
Janux Therapeutics, Inc.(JANX)121,64292,949-28,693$4.58M$3.89M1.15%-$686.2K
IDEAYA Biosciences, Inc.(IDYA)87,393101,787+14,394$3.83M$3.57M1.05%-$261.1K
Spyre Therapeutics, Inc.(SYRE)62,253150,450+88,197$2.36M$3.54M1.04%+$1.18M
Perspective Therapeutics, Inc.(CATX)0343,810+343,810$0$3.43M1.01%+$3.43M
Jasper Therapeutics, Inc.(JSPR)129,211143,775+14,564$3.79M$3.26M0.96%-$529.9K
Black Diamond Therapeutics I0674,198+674,198$0$3.14M0.92%+$3.14M
Vigil Neuroscience Inc0744,412+744,412$0$2.98M0.88%+$2.98M
Neurogene Inc.(NGNE)078,601+78,601$0$2.86M0.84%+$2.86M
Silence Therapeutics plcADS(SLN)0124,866+124,866$0$2.37M0.70%+$2.37M
Protara Therapeutics, Inc.(TARA)168,442984,113+815,671$675.5K$2.05M0.60%+$1.37M
Helix Acquisition Corp IiCL A200,000200,0000$2.08M$2.04M0.60%-$36.0K
Surrozen, Inc.(SRZN)0143,510+143,510$0$1.57M0.46%+$1.57M
Perceptive Cap Solutions CorCL A
CL A ORD SHS
0150,000+150,000$0$1.51M0.44%+$1.51M
Praxis Precision Medicines, Inc.(PRAX)26,89329,259+2,366$1.64M$1.21M0.36%-$430.9K
Acelyrin Inc714,7730-714,773$4.82M$0—-$4.82M
Achilles Therapeutics PlcADS1,385,7500-1,385,750$1.73M$0—-$1.73M
Anaptysbio Inc269,5480-269,548$6.07M$0—-$6.07M
Annexon, Inc.(ANNX)605,1170-605,117$4.34M$0—-$4.34M
Astria Therapeutics Inc230,2730-230,273$2.68M$0—-$2.68M
Avadel Pharmaceuticals Plc223,6600-223,660$3.78M$0—-$3.78M
Cargo Therapeutics Inc51,1260-51,126$1.14M$0—-$1.14M
CG Oncology, Inc.(CGON)40,7230-40,723$1.79M$0—-$1.79M
Dianthus Therapeutics, Inc.(DNTH)43,4560-43,456$1.30M$0—-$1.30M
Disc Medicine, Inc.(IRON)60,1290-60,129$3.74M$0—-$3.74M
Effector Therapeutics Inc132,7930-132,793$1.91M$0—-$1.91M
Eli Lilly and Company(LLY)15,0670-15,067$11.72M$0—-$11.72M
Kyverna Therapeutics, Inc.(KYTX)41,0000-41,000$1.02M$0—-$1.02M
MoonLake ImmunotherapeuticsCL A(MLTX)90,6470-90,647$4.55M$0—-$4.55M
Newamsterdam Pharma Company
ORDINARY SHARES
80,3340-80,334$1.90M$0—-$1.90M
Soleno Therapeutics Inc115,8330-115,833$4.96M$0—-$4.96M
Tarsus Pharmaceuticals, Inc.(TARS)222,2530-222,253$8.08M$0—-$8.08M
Taysha Gene Therapies, Inc.(TSHA)1,087,7850-1,087,785$3.12M$0—-$3.12M
Tourmaline Bio Inc274,2190-274,219$6.28M$0—-$6.28M
Page 1 of 1
STEMPOINT CAPITAL LP — 13F Holdings — Q2 2024 | TickerTrail